Canada markets close in 56 minutes

  • S&P/TSX

    18,358.49
    +232.77 (+1.28%)
     

  • S&P 500

    3,838.04
    +69.57 (+1.85%)
     

  • DOW

    31,460.71
    +536.57 (+1.74%)
     

  • CAD/USD

    0.7898
    +0.0000 (+0.01%)
     

  • CRUDE OIL

    66.10
    +2.27 (+3.56%)
     

  • BTC-CAD

    62,480.81
    +1,642.32 (+2.70%)
     

  • CMC Crypto 200

    984.92
    +41.75 (+4.43%)
     

  • GOLD FUTURES

    1,697.00
    -3.70 (-0.22%)
     

  • RUSSELL 2000

    2,168.04
    +21.12 (+0.98%)
     

  • 10-Yr Bond

    1.5490
    -0.0010 (-0.06%)
     

  • NASDAQ

    12,910.86
    +187.39 (+1.47%)
     

  • VOLATILITY

    25.33
    -3.24 (-11.34%)
     

  • FTSE

    6,630.52
    -20.36 (-0.31%)
     

  • NIKKEI 225

    28,864.32
    -65.79 (-0.23%)
     

  • CAD/EUR

    0.6627
    +0.0035 (+0.53%)
     

Andrew Wiggins with a 2-pointer vs the Utah Jazz

Andrew Wiggins (Golden State Warriors) with a 2-pointer vs the Utah Jazz, 01/23/2021

Latest Stories

  • The mask mandate culture wars are not going away

    As some states, most notably Texas, begin to lift mask mandates, the Biden administration is launching an informal but energetic campaign to prevent others from following suit.

  • Social Security scammers have a new game: They're impersonating agency employees by texting photos of phony badges

    Scammers are out to steal Social Security numbers and your money. Some claim you need to transfer money out of a bank account to them to fix problems.

  • TikTok users are freaking out over these 'easy-fit,' summer-ready shorts: 'The comfiest shorts I've ever owned'

    If you've been living in sweatsuits for the past few months, with these shorts, that doesn't have to change.

  • Stock market news live updates: Stocks mixed as rate concerns rise after strong jobs report

    Stocks turned negative after the Labor Department's February jobs report handily exceeded expectations, reaffirming the building momentum in the economic recovery, but also stoking a rise in Treasury yields and concerns over an economic overheating.

  • President Biden holds a roundtable on the American Rescue Plan

    President Biden participates in a roundtable on the American Rescue Plan.

  • Was A Major 'WandaVision' Moment Really Just For This Dirty Joke?

    Twitter reacts to "WandaVision" finally exposing one character.

  • Good Girls EPs Talk Season 4: 'Beth and Dean Are on a Collision Course' — Plus, Intel on Rio's Upcoming Backstory

    The Good Girls are (finally!) back this Sunday, and while they’re still breaking all sorts of bad, the hurdles that stand before them are lining up like never before. When we last left the ladies, Beth and Dean (played by Christina Hendricks and Matthew Lillard) were prepping the launch of Boland Bubbles, a hot tub […]

  • 3 Canadian Stocks That Could Double in 2021

    These three incredible Canadian stocks are top buys today offer strong potential to double investors money by year's end. The post 3 Canadian Stocks That Could Double in 2021 appeared first on The Motley Fool Canada.

  • Hollysys Automation Technologies Ltd (HOLI) Q2 2021 Earnings Call Transcript

    Ladies and gentlemen, thank you for standing by, and welcome to the Hollysys Automation Technologies Earnings Conference Call for Fiscal Year 2021 Second Quarter ended December 31, 2020. Please go ahead, Mr. Xia.

  • 3 High-Dividend REITs to Buy in March

    These three REITs aren't only providing attractive dividend income today but are also positioned for long-term growth.

  • Riley Keough Joins Chris Pratt In ‘The Terminal List’ Amazon Conspiracy Thriller Series

    Riley Keough is set as a lead opposite Chris Pratt and Constance Wu in Amazon’s conspiracy-thriller series The Terminal List, based on Jack Carr’s bestselling novel. Taylor Kitsch and Jeanne Tripplehorn also star in the series, which Pratt executive produces along with Antoine Fuqua, who directs, and writer David DiGilio. The Terminal List is a […]

  • The Herzfeld Caribbean Basin Fund, Inc. TENDER OFFER RESULTS

    MIAMI BEACH, Fla., March 05, 2021 (GLOBE NEWSWIRE) -- Thomas J. Herzfeld Advisors, Inc., an SEC-registered investment adviser, and The Herzfeld Caribbean Basin Fund, Inc. (Nasdaq: CUBA) (the “Fund”) today announced the final results of the Fund’s offer to purchase up to 5% of outstanding shares of the Fund at 97.5% of NAV as of the close of ordinary trading on the NASDAQ Capital Market (the “NASDAQ”) on March 4, 2021, the expiration date. Based on the final count by American Stock Transfer & Trust Co., LLC (“AST”), the depositary for the tender offer, a total of 2,460,234.322 common shares of the Fund were validly tendered and not withdrawn. The total amount of shares tendered exceeded the offer amount, and the Fund will purchase tendered shares on a pro rata basis. Subject to final delivery of all tendered shares, the proration factor for shares purchased pursuant to the offer is 12.4656%. In accordance with the terms and conditions of the tender offer, the Fund has accepted for payment all 306,683 common shares subject to the tender offer. The purchase price per share is determined to be $6.7958. Payment for the shares accepted for purchase under the tender offer and return of all other shares tendered and not purchased will occur promptly. AST Fund Solutions, LLC is the information agent for the Offer. Shareholders with questions may call AST Fund Solutions, LLC at (866) 406-2285. About Thomas J. Herzfeld Advisors, Inc. Thomas J. Herzfeld Advisors, Inc., founded in 1984, is an SEC registered investment advisor, specializing in investment analysis and account management in closed-end funds. The Firm also specializes in investment in the Caribbean Basin. The HERZFELD/CUBA division of Thomas J. Herzfeld Advisors, Inc. serves as the investment advisor to The Herzfeld Caribbean Basin Fund, Inc. a publicly traded closed-end fund (NASDAQ: CUBA). More information about the advisor can be found at www.herzfeld.com. Past performance is no guarantee of future performance. An investment in the Fund is subject to certain risks, including market risk. In general, shares of closed-end funds often trade at a discount from their net asset value and at the time of sale may be trading on the exchange at a price which is more or less than the original purchase price or the net asset value. There can be no assurance that any Share repurchases will reduce or eliminate the discount of the Fund’s market price to the Fund’s net asset value per share. An investor should carefully consider the Fund’s investment objective, risks, charges and expenses. Please read the Fund’s disclosure documents before investing.

  • Vor Biopharma to Present at the Barclays Global Healthcare Conference

    CAMBRIDGE, Mass., March 05, 2021 (GLOBE NEWSWIRE) -- Vor Biopharma (Nasdaq: VOR), a cell therapy company pioneering engineered hematopoietic stem cell (eHSC) therapies combined with targeted therapies for the treatment of cancer, today announced that the Company will be participating in the Barclays Global Healthcare Conference, which will take place virtually on March 9-11, 2021. Robert Ang, MBBS, MBA, Vor’s President and Chief Executive Officer, and Nathan Jorgensen, PhD, Chief Financial Officer, are scheduled to present on Thursday, March 11, 2021, at 3:00 p.m. E.T. A live webcast of the presentation can be accessed via the Investors section of the Company's website at www.vorbio.com. An archived replay of the webcast will be available on the Company's website following the conference. About Vor Biopharma Vor Biopharma is a cell therapy company that aims to transform the lives of cancer patients by pioneering engineered hematopoietic stem cell (eHSC) therapies to create next-generation, treatment-resistant transplants that unlock the potential of targeted therapies. By removing biologically redundant proteins from eHSCs, we design these cells and their progeny to be treatment-resistant to complementary targeted therapies, thereby enabling these therapies to selectively destroy cancerous cells while sparing healthy cells. Contacts: Investor: Constantine Davides, CFAWestwicke +1 339-970-2846 constantine.davides@westwicke.com Media: Mary Carmichael Ten Bridge Communications +1 617-413-3543 mary@tenbridgecommunications.com

  • Boussard & Gavaudan Holding Limited (eur) :APPOINTMENT OF DIRECTOR

    Boussard & Gavaudan Holding Limiteda closed-ended investment company incorporated with limited liability under the laws of Guernsey with registration number 45582 Legal Entity Identifier: 5493002XNM3W9D6DF327 APPOINTMENT OF DIRECTOR The Board of the Company is pleased to announce the appointment of Mr Bruce James as a non-executive director of the Company. Mr James is the Managing Director of Montrose Asset Management Limited, a Guernsey based company specializing in investment management. He is a graduate of the University of Cape Town and a UK qualified solicitor. He is a Chartered Member of the Institute for Securities and Investments and a member of STEP. Bruce also holds the IoD Certificate in Company Direction and is a member of the Institute of Directors. Mr James holds a range of non-executive directorships on fund management and fund investment companies. As at the date of this announcement, he holds or held, within the previous five years, the following directorship in other publicly quoted companies: CurrentPast Cayzer Continuation PCC Limited Mr James and persons closely associated with him are not beneficially interested in any Ordinary Shares of no par value shares in the Fund. Andrew Henton, Chairman of the Company, said: “We are delighted to welcome Mr James to the Company. We have no doubt that his extensive experience and sector knowledge within the investment company arena will be of considerable support to the Fund as we continue to focus on providing stable income and capital growth to our shareholders. We look forward to Bruce’s future contribution to the Fund.” There is no information concerning Mr James which is required to be disclosed pursuant to Listing Rule 9.6.13 R (2) to (6) inclusive and the Board consider him to be independent on appointment per the AIC Code of Corporate Governance. 5 March 2021 END For further information, please contact: Boussard & Gavaudan Investment Management LLP +44 20 3751 5400Emmanuel Gavaudan (London) +44 203 751 5389Francois Xavier Baud (London) +44 203 751 5395 www.bgholdingltd.com The Company is established as a closed-ended investment company domiciled in Guernsey. The Company has been authorised by the Guernsey Financial Services Commission as an authorised closed-ended investment scheme. The Company is registered with the Dutch Authority for the Financial Markets as a collective investment scheme pursuant to article 2:73 in conjunction with 2:66 of the Dutch Financial Supervision Act (Wet op het financieel toezicht). The shares of the Company (the "Shares") are listed on Euronext Amsterdam. The Shares are also listed on the Official List of the UK Listing Authority and admitted to trading on the London Stock Exchange plc's main market for listed securities. This is not an offer to sell or a solicitation of any offer to buy any securities in the United States or in any other jurisdiction. This announcement is not intended to and does not constitute, or form part of, any offer or invitation to purchase any securities or the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance or transfer of the securities referred to in this announcement in any jurisdiction in contravention of applicable law. Neither the Company nor BG Fund Plc has been, and neither will be, registered under the US Investment Company Act of 1940, as amended (the "Investment Company Act"). In addition the securities referenced in this announcement have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act"). Consequently any such securities may not be offered, sold or otherwise transferred within the United States or to, or for the account or benefit of, US persons except in accordance with the Securities Act or an exemption therefrom and under circumstances which will not require the issuer of such securities to register under the Investment Company Act. No public offering of any securities will be made in the United States. You should always bear in mind that: all investment is subject to risk; results in the past are no guarantee of future results; the investment performance of BGHL may go down as well as up. You may not get back all of your original investment; and if you are in any doubt about the contents of this communication or if you consider making an investment decision, you are advised to seek expert financial advice. This communication is for information purposes only and the information contained in this communication should not be relied upon as a substitute for financial or other professional advice. END OF ANNOUNCEMENT Attachment 2020 03 05 - BGHL - Appointment of Bruce James (non-executive director) - v2

  • Boussard & Gavaudan Holding Limited (gbp) : Appointment of Director

    Boussard & Gavaudan Holding Limiteda closed-ended investment company incorporated with limited liability under the laws of Guernsey with registration number 45582 Legal Entity Identifier: 5493002XNM3W9D6DF327 APPOINTMENT OF DIRECTOR The Board of the Company is pleased to announce the appointment of Mr Bruce James as a non-executive director of the Company. Mr James is the Managing Director of Montrose Asset Management Limited, a Guernsey based company specializing in investment management. He is a graduate of the University of Cape Town and a UK qualified solicitor. He is a Chartered Member of the Institute for Securities and Investments and a member of STEP. Bruce also holds the IoD Certificate in Company Direction and is a member of the Institute of Directors. Mr James holds a range of non-executive directorships on fund management and fund investment companies. As at the date of this announcement, he holds or held, within the previous five years, the following directorship in other publicly quoted companies: CurrentPast Cayzer Continuation PCC Limited Mr James and persons closely associated with him are not beneficially interested in any Ordinary Shares of no par value shares in the Fund. Andrew Henton, Chairman of the Company, said: “We are delighted to welcome Mr James to the Company. We have no doubt that his extensive experience and sector knowledge within the investment company arena will be of considerable support to the Fund as we continue to focus on providing stable income and capital growth to our shareholders. We look forward to Bruce’s future contribution to the Fund.” There is no information concerning Mr James which is required to be disclosed pursuant to Listing Rule 9.6.13 R (2) to (6) inclusive and the Board consider him to be independent on appointment per the AIC Code of Corporate Governance. 5 March 2021 END For further information, please contact: Boussard & Gavaudan Investment Management LLP +44 20 3751 5400Emmanuel Gavaudan (London) +44 203 751 5389Francois Xavier Baud (London) +44 203 751 5395 www.bgholdingltd.com The Company is established as a closed-ended investment company domiciled in Guernsey. The Company has been authorised by the Guernsey Financial Services Commission as an authorised closed-ended investment scheme. The Company is registered with the Dutch Authority for the Financial Markets as a collective investment scheme pursuant to article 2:73 in conjunction with 2:66 of the Dutch Financial Supervision Act (Wet op het financieel toezicht). The shares of the Company (the "Shares") are listed on Euronext Amsterdam. The Shares are also listed on the Official List of the UK Listing Authority and admitted to trading on the London Stock Exchange plc's main market for listed securities. This is not an offer to sell or a solicitation of any offer to buy any securities in the United States or in any other jurisdiction. This announcement is not intended to and does not constitute, or form part of, any offer or invitation to purchase any securities or the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance or transfer of the securities referred to in this announcement in any jurisdiction in contravention of applicable law. Neither the Company nor BG Fund Plc has been, and neither will be, registered under the US Investment Company Act of 1940, as amended (the "Investment Company Act"). In addition the securities referenced in this announcement have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act"). Consequently any such securities may not be offered, sold or otherwise transferred within the United States or to, or for the account or benefit of, US persons except in accordance with the Securities Act or an exemption therefrom and under circumstances which will not require the issuer of such securities to register under the Investment Company Act. No public offering of any securities will be made in the United States. You should always bear in mind that: all investment is subject to risk; results in the past are no guarantee of future results; the investment performance of BGHL may go down as well as up. You may not get back all of your original investment; and if you are in any doubt about the contents of this communication or if you consider making an investment decision, you are advised to seek expert financial advice. This communication is for information purposes only and the information contained in this communication should not be relied upon as a substitute for financial or other professional advice. END OF ANNOUNCEMENT Attachment 2020 03 05 - BGHL - Appointment of Bruce James (non-executive director) - v2

  • Why MicroStrategy Stock Pulled Back Today

    If you guessed this company was going to keep buying Bitcoin, then give yourself a pat on the back for being right.

  • Dog Owners Say This Best-Selling Car Hammock ‘Keeps Back Seats Pristine’

    If your dog is tagging along, consider this a must-have

  • At least 10 dead in bombing at restaurant in Somali capital

    Police spokesman Sadiq Ali Adan blamed the attack on the local al-Shabab extremist group, which is linked to al-Qaida and often targets Mogadishu with bombings. Security in Mogadishu had been especially heavy, with thousands of government forces deployed in anticipation of a planned demonstration on Saturday by an alliance of opposition leaders over the country's delayed national election.

  • SAmerica worried as European clubs won't release players

    CONMEBOL said on Friday that FIFA was “looking for a solution to the stalemate” as Manchester City's Pep Guardiola became the latest manager to reveal he won't let his players travel to international matches this month if they have to quarantine on their return. “They are not going to fly, for sure,” Guardiola said.

  • Initial public offerings scheduled to debut next week

    NEW YORK — The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings. Week of March 8 Coupang - Seoul, South Korea, 120 million shares, priced $27-$30, managed by Goldman Sachs/Allen & Company. Proposed NYSE CPNG. Business: Korea e-commerce site. First High-School Education Group - Kunming, China, 7.5 million shares, priced $9.50-$10.50, managed by The Benchmark Company/AMTD Global Markets. Proposed NYSE symbol FHS. Business: Operates private high schools and provides tutoring services in China. Hayward Holdings - Berkeley Heights, N.J., 40.3 million shares, priced $17-$19, managed by BofA Securities/Goldman Sachs. Proposed NYSE HAYW. Business: Supplier of pool equipment and systems. JOANN - Hudson, Ohio, 10.9 million shares, priced $15-$17, managed by BofA Securities/Credit Suisse. Business: Multi-channel fabric and crafts retailer with about 860 stores. Jowell Global - Shanghai, China, 3.7 million shares, priced at $7, managed by Network 1 Financial Securities. Proposed Nasdaq symbol JWEL. Business: Operates an e-commerce platform for cosmetics and health products in China. Universe Pharmaceuticals - Jiangxi, China, 5 million shares, priced $5-$7, managed by Univest Securities. Proposed Nasdaq symbol UPC. Business: Chinese pharmaceutical specializing in traditional Chinese medicine derivatives. The Associated Press